Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Bupropion Sustained Release
Treatment for Amphetamine use disorders
Typical Dosage: 150mg SR twice daily to 200mg SR twice daily
Effectiveness
45%
Safety Score
60%
Clinical Trials
22
Participants
2.6K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
60
DangerousModerateSafe
Treatment Details
Dosage Range
150mg SR twice daily to 200mg SR twice daily
Time to Effect
2-4 weeks
Treatment Duration
12-24 weeks
Evidence Quality
MODERATENumber Needed to Treat (NNT)
10(Treat 10 patients to see 1 additional successful outcome)
Confidence Score
65%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$250
Monitoring:$200
Side Effect Mgmt:$75
Total Annual:$525
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODQALYs Gained
0.15
Outcome-Based Costs
Cost per Responder
$1,500
Cost per Remission
$2,625
Bupropion Sustained Release Outcomes
for Amphetamine use disorders
Efficacy Outcomes
Overall Effectiveness
+45%
Response Rate
+35%
Remission Rate
+20%
Common Side Effects
Insomnia
+30%
Dry mouth
+18%
Nausea
+12%
Headache
+8%
Seizures
+0.1%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov